SCHEDULE: Vanguard Group Exits Neogen Stake Post-Realignment

The Vanguard Group, Inc. has reported a 0% beneficial ownership in Neogen Corp common stock following an internal realignment effective January 12, 2026.

Summary

• The Vanguard Group, Inc. (TVG) filed an Amendment No. 15 to Schedule 13G for Neogen Corp, reporting a 0% beneficial ownership of Neogen Corp's common stock.
• This change is a direct result of an internal realignment within The Vanguard Group, Inc. that became effective on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of TVG will now report their beneficial ownership separately, disaggregated from The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these newly disaggregated subsidiaries and/or business divisions.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Neogen Corp.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for Neogen Corp, as the change in reported ownership by The Vanguard Group is due to an internal structural realignment rather than a direct investment decision related to Neogen's fundamentals.

Positives

• The filing clarifies a structural change within The Vanguard Group, Inc., indicating a routine internal adjustment rather than a strategic divestment based on Neogen's performance.

Negatives

• The Vanguard Group, Inc. no longer directly holds beneficial ownership in Neogen Corp, which might be perceived negatively by some investors who track large institutional holdings, despite the internal realignment explanation.

Risks

• No specific risks related to Neogen Corp's operations or financial health are mentioned in this filing. The primary 'risk' is the potential for misinterpretation by investors regarding the reason for The Vanguard Group's reported 0% stake.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that such internal realignments by large asset managers like The Vanguard Group are not uncommon. They often reflect operational efficiencies or compliance adjustments rather than a change in investment thesis regarding the underlying company, Neogen Corp. This type of filing primarily impacts how Vanguard's holdings are reported rather than signaling a direct market action against Neogen.

Stakeholder Impact

• Shareholders may initially perceive a major institutional investor reducing its stake, but understanding the internal realignment context should mitigate concerns. The actual underlying holdings by Vanguard's various funds may still exist, just reported differently.
• Investment professionals will need to track the disaggregated filings from Vanguard's subsidiaries to get a complete picture of Vanguard's overall exposure to Neogen Corp.

Next Steps

• The Vanguard Group's subsidiaries or business divisions will now report their beneficial ownership of Neogen Corp securities separately in future filings.

Key Dates

Recommendation

The filing indicates a procedural change in how The Vanguard Group reports its beneficial ownership due to an internal realignment, rather than a fundamental shift in investment strategy concerning Neogen Corp. While the direct reported stake by The Vanguard Group, Inc. is now 0%, this does not necessarily mean a complete divestment by all Vanguard-managed funds. Therefore, this filing alone does not warrant a change in investment recommendation for Neogen Corp, maintaining a 'hold' stance until further fundamental information becomes available.

Keywords

Neogen Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Internal Realignment, Common Stock, SEC Filing, Ownership Change